共 30 条
[1]
ADAGU IS, 2002, CHEMOTHERAPY, V49, P103
[2]
[Anonymous], 1997, Wkly Epidemiol Rec, V72, P97
[3]
[Anonymous], 2007, CURR BIOACT COMPD, DOI DOI 10.2174/157340707780809590
[4]
IMMUNOPHARMACOLOGICAL PROFILE OF HWA-486, A NOVEL ISOXAZOL DERIVATIVE .2. INVIVO IMMUNOMODULATING EFFECTS DIFFER FROM THOSE OF CYCLOPHOSPHAMIDE, PREDNISOLONE, OR CYCLOSPORINE-A
[J].
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY,
1986, 8 (02)
:199-204
[5]
Brandt H, 1970, Hum Pathol, V1, P351
[6]
Design and synthesis of N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [muraglitazar BMS-298585], a novel peroxisome proliferator-activated receptor α/γ dual agonist with efficacious glucose and lipid-lowering activities
[J].
JOURNAL OF MEDICINAL CHEMISTRY,
2005, 48 (06)
:2248-2250
[8]
Fromtling R. A., 1986, DRUG TODAY, V20, P235
[9]
GIFFIN FD, 1982, ANTIMICROB AGENTS CH, V22, P342